Skip to content

Schedule

Accommodation

Contact Us

Passenger Information Request Forms are being emailed to participants on a rolling basis.
Forms MUST be returned by 30 September in order to attend Forum 30.

ICCBBA Forum 30 MPHO Logo14-15 November 2024
Rome, Italy
The international conference on achieving and sustaining a global consensus for Medical Products of Human Origin (MPHO) safety, biovigilance, and traceability and to protect patients in need of MPHO worldwide. 
 
Stay Informed of the Latest from Forum 30!
a special thanks to:
CNS_400x-1
National competent authority for blood and blood components acting as coordinator of the national system. Among others, it is responsible for blood inspectors' qualification through training activities. Learn More
CNT_400x
National competent authority for organs, tissues, cells and MAR coordinating activities from donation to transplantation. Among others, it is responsible for inspectors' qualification through training activities. Learn More
ICCBBA ISBT 128 Standards logo
The International Council for Commonality in Blood Banking Automation (ICCBBA) is the international standards organization responsible for the management and development of the ISBT 128 Standard. Learn More

Tracking, Technology and Tomorrow

Join us in Rome for a transformative experience at the Forum 30 Global Conference!

A pivotal event aimed at advancing the safety and traceability of Medical Products of Human Origin (MPHO) worldwide. Organized by ICCBBA in collaboration with the Italian national competent authorities for blood (CNS) and cells/tissues (CNT), this invitation-only event promises a unique perspective and approach. Mark your calendars, as we gather in the city of Rome, Italy, to embark on a transformative journey.

Together, let's unlock new perspectives, forge meaningful connections and chart the course towards enhanced safety and traceability of Medical Products of Human Origin worldwide. Your participation is not just a contribution to the dialogue; it's a commitment to advancing patient care and donor well-being. Save the date and be a part of this pivotal meeting. Formal invitations with full information will be extended shortly.

Map to Forum 30 at the Istituto Superiore di Sanita
    Day 1
Istituto Superiore
di Sanità (ISS)
 
Start Time: 9:00
End Time: 16:30
Need, Safety, Risk and Availability
How do we achieve the balance between these factors?
Day 2
Istituto Superiore
di Sanità (ISS)
 
Start Time: 8:30
End Time: 15:30
What makes certain MPHO different?
Selected MPHO Across Complex Pathways

Schedule of Events

Day 1
Istituto Superiore
di Sanità (ISS)
 14 November 2024
 
Check In: 8:00
Start Time: 9:00
Break: 10:30 - 11:00
Break: 13:00 - 13:10
End Time: 16:30
9:00 - 9:20
Welcome and Opening
Aims of the Meeting and Expected Outcomes
Presenters: 4
 
9:30 - 10:30
Need, Safety, Risk and Availability
How do we achieve the balance between these factors?
Presenters: 3 
  • Joint welcome by the conference co-organizers
Day 2
Istituto Superiore
di Sanità (ISS)
15 November 2024
 
Start Time: 8:30
Break: 10:40 - 11:00
Break: 12:15 - 13:30
End Time: 15:30
8:30 - 9:30
Selected MPHO Across Complex Pathways
Particular aspects the makes them different from other MPHO
Presenters: 3 
  • Tissues: What makes them different?
  • Cells: What makes them different?
  • Reproductive tissues: What makes them different?
Day 01
Istituto Superiore Di Sanità (ISS)
Start Time: 9:00  |  End Time: 16:30
  
Session 01
Need, Safety, Risk and Availability
How do we achieve the balance between these factors?
 
Session 02
When Things Go Wrong
Applied traceability in real-world MPHO
 
 
Session 03
Feedback and Conclusions
Review the previous sessions back in the main auditorium
 
Session 04
Donor-related and processing threats affecting MPHO and lessons learned
Emerging infectious disease threats and process-related errors
 


Summary and Close of Day 01
Day 02
Istituto Superiore Di Sanità (ISS)
Start Time: 8:30  |  End Time: 15:30
 
Session 05
What makes certain MPHO different?
Selected MPHO Across Complex Pathways
 
 Session 06
MPHO-based Therapies in the Next 20 Years
What is coming tomorrow that we need to think about today?
  
 Session 07
In Technology We Trust
How healthcare informatics standards & technologies will help us
 
 Session 08
From Forum 25 to Forum 30
How far have we come since 2019?   
 
 
 
 

Summary and Close of Day 02

 

Accommodation and Networking Event

Transportation

To facilitate your journey, we've curated comprehensive transportation options.

  • Air Travel

  • Airport Meet & Greet & Train Service

  • Hotel/Venue Shuttle Service

Learn More
Lodging

We have partnered with hotels in the vicinity for your stay.

  • Hotel Atlantico

  • Hotel Mediterraneo

  • Hotel Massimo D’azegli

Learn More
Networking Event

Join Us for the Networking Event at Royal Space Rome!

  • FREE For Attendees!

  • Date: 14th November

  • Time: 18:30 - 22:00|

Learn More

Invited Speakers

Ziggy-1
Matthew Kuehnert
Dr. Kuehnert serves on the ICCBBA board of directors as Treasurer. He is a Professor at Hackensack Meridian School of Medicine, and a fellow of the American College of Physicians and the Infectious Diseases Society of America.
 
From 2003 to 2017, Dr. Kuehnert was Director of the Office of Blood, Organ, and Other Tissue Safety at the Centers for Disease Control and Prevention (CDC). From 2017 to 2021, he was medical director of MTF Biologics, a nonprofit tissue processor founded in 1987, where he is currently a consultant. He is deputy editor-in-chief of the journal Emerging Infectious Diseases, published by CDC.
 
He completed his undergraduate education at the University of California at San Diego and received his medical degree from Columbia University’s College of Physicians & Surgeons. He trained in Internal Medicine at Stanford University and the University of California at San Francisco, and in Infectious Diseases at Emory University.
Ziggy-1
Bootstrap Example
Ziggy-1
Dragoslav Domanović
Dragoslav Domanović is a medical doctor and a specialist in transfusion medicine. He holds a master's degree and a doctorate in the investigation of peripheral blood stem cells. Working experiences gained at the National Institute for Transfusion Medicine Ljubljana, Slovenia. Last 10 years he has been working as a principal expert for the microbiological safety of substances of human origin at the European Centre for Disease Prevention and Control, Stockholm, Sweden. The main expertise and areas of interest: scientific advice in the transmission of communicable diseases through substances of human origin response to outbreaks and risk assessments of infectious diseases transmissible through substances of human origin preparedness for the safety of supply with substances of human origin epidemiology of donor-derived infection emerging infectious diseases and the safety of substances of human origin. Since January 2022, he has been working part-time as a medical director of the European Blood Alliance.
Ziggy-1

Zbigniew M Szczepiorkowski

Chairman, ICCBBA

Karen Moniz

Karen Moniz

Technical Director, ICCBBA

Ziggy-1

Zbigniew M Szczepiorkowski

Chairman, ICCBBA

Karen Moniz

Karen Moniz

Technical Director, ICCBBA

Ziggy-1

Zbigniew M Szczepiorkowski

Chairman, ICCBBA

Karen Moniz

Karen Moniz

Technical Director, ICCBBA

Ziggy-1

Zbigniew M Szczepiorkowski

Chairman, ICCBBA

Karen Moniz

Karen Moniz

Technical Director, ICCBBA

logo_Forum25_white-01-2

Find out about the original Forum conference that took place in 2019!

 

Forum 25 in Review